Gopa Iyer, MD
Genitourinary Medical Oncologist & Early Drug Development Specialist
My Role at MSK
Patient Reviews
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Make an Appointment
New Patients
Scheduling an appointment is easy. Click or call 646-497-9068— we’re available 24 hours a day, 7 days a week
Current Patients
Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.
Clinical Trials
- Clinical Trials Investigated by Dr. Iyer
- A Phase 1 Study of TYRA-300 in People with Advanced Bladder Cancer
- A Phase 1a Study of LOXO-435 in People with Advanced Solid Tumors Containing FGFR3 Gene Changes
- A Phase 2 Study of Disitamab Vedotin Alone and with Pembrolizumab Immunotherapy in People with Inoperable or Metastatic Urothelial Cancer
- A Phase 2 Study of Enfortumab Vedotin in People with Urothelial Cancer of the Upper Urinary Tract
Read more
- A Phase II Study of Chemotherapy without Surgery in Patients with Muscle-Invasive Bladder Cancer and Certain Gene Mutations
- A Pilot Study Assessing Immunotherapy with Nivolumab Alone or with Ipilimumab Before Surgery for Patients with Muscle-invasive Bladder Cancer Who Cannot Have Cisplatin-Based Chemotherapy
- Clinical Trials Co-Investigated by Dr. Iyer
- A Phase 1 Study of TNG908 in People with Sarcoma, Mesothelioma, or Glioblastoma
- A Phase 1a Study of LY4101174 in People With Bladder or Prostate Cancer
- A Phase 2 Study of Datopotamab Deruxtecan Alone or With Other Anti-Cancer Drugs in People Endometrial, Ovarian, and Urothelial Cancers
- A Phase 2/3 Study Assessing Tumor DNA in the Blood to Guide the Use of Immunotherapy After Bladder Cancer Surgery
- A Phase I Study of ADP-A2M4CD8 with or without Nivolumab Immunotherapy in People with Urothelial Cancer, Non-Small Cell Lung Cancer, or Endometrial Cancer
- A Phase II Study of Ado-Trastuzumab Emtansine in Patients with Cancers Driven by HER2
- A Phase II Study of Oral Erdafitinib in People with Recurrent Non-Invasive Bladder Cancer
- A Phase II Study of Trastuzumab Deruxtecan in People with HER2-Positive Solid Tumors
Find a Clinical Trial for You
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trials
